Literature DB >> 4070561

Hypoxic fraction and binding of misonidazole in EMT6/Ed multicellular tumor spheroids.

A J Franko.   

Abstract

Misonidazole has been shown to bind selectively to hypoxic cells in tissue culture and to cells which are presumed to be chronically hypoxic in EMT6 spheroids and tumors. Thus it has considerable potential as a marker of hypoxic cells in vivo. To further evaluate this potential EMT6/Ed spheroids were used to quantitate misonidazole binding under conditions which resulted in hypoxic fractions between 0 and 1. Hypoxic fractions were quantitated using radiation survival curves. A doubling of the oxygen in the gas phase to 40% was required to fully oxygenate all chronically hypoxic cells. The patterns of binding of 14C-labeled misonidazole determined by autoradiography were consistent with the regions of radiobiological hypoxia as predicted by oxygen diffusion theory. The overall uptake of 3H-labeled misonidazole by spheroids correlated well with the hypoxic fraction, although binding to aerobic cells and necrotic tissue contributed appreciably to the total label in the spheroids. It is concluded that misonidazole is an excellent marker of hypoxia in EMT6/Ed spheroids at the microscopic level, and the total amount bound per spheroid provides a potentially useful measure of the hypoxic fraction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4070561

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  5 in total

1.  Multicellular membranes as an in vitro model for extravascular diffusion in tumours.

Authors:  D S Cowan; K O Hicks; W R Wilson
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 2.  Multicellular spheroids. A review on cellular aggregates in cancer research.

Authors:  W Mueller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

3.  In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia.

Authors:  Paul D Bonnitcha; Amy L Vāvere; Jason S Lewis; Jonathan R Dilworth
Journal:  J Med Chem       Date:  2008-04-17       Impact factor: 7.446

4.  Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours.

Authors:  J A Raleigh; G G Miller; A J Franko; C J Koch; A F Fuciarelli; D A Kelly
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

5.  Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours.

Authors:  R M Phillips; P M Loadman; B P Cronin
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.